New Jersey vs Texas on USAspending: $8.1B vs $72.7B

More awards in New Jersey, more dollars in Texas

Texas’s $72.7B stacked stock sits well above New Jersey’s $8.1B. Census population leans Texas: 31,290,831 versus 9,500,851. Intensity follows the dollar ranking. $686.1 per capita versus $92.49 is a wide gap. Cite those packet ratios beside the Census counts; they are not a second copy of $72.7B and $8.1B.

Award volume runs the other way. New Jersey’s 1,162,765 awards versus Texas’s 530,634 is a thicker action log on the smaller dollar file. Row count is not average award size. Cite USAspending.gov. Do not invent a mean from 1,162,765 or 530,634.

Pharmaceutical preparation manufacturing on both sides

New Jersey’s lead NAICS is pharmaceutical preparation manufacturing. Texas’s lead NAICS is the same label. A shared drug-manufacturing peak is a first filter on $8.1B and $72.7B, not a claim that the two mixes are interchangeable. The same industry name does not make $92.49 and $686.1 the same intensity.

The 1,162,765 New Jersey awards and 530,634 Texas awards include many actions outside that pharmaceutical label. Use the New Jersey and Texas state hubs for agencies and recipients. Both peaks are USAspending.gov obligation mixes. Outlays are not in the packet.

New Jersey’s 1,162,765 awards sit on $8.1B. Texas’s 530,634 awards sit on $72.7B. FY2026 of $878.7M versus $21.5B preserves the stacked ranking. The shared pharmaceutical preparation manufacturing label does not make those files interchangeable. Cite USAspending.gov.

FY2026: New Jersey’s $878.7M versus Texas’s $21.5B

Fiscal year 2026 obligations are $878.7M in New Jersey and $21.5B in Texas. Recency preserves Texas’s stacked dollar lead. Treat the year as a recency slice of obligations, not as Treasury cash already paid.

Do not divide $878.7M or $21.5B by 1,162,765 or 530,634 all-years awards. Spending per capita of $92.49 and $686.1 already sits beside Census counts of 9,500,851 and 31,290,831. Cite USAspending.gov for both cuts.

What 1,162,765 awards look like on an $8.1B stock

New Jersey’s $8.1B on 9,500,851 people produces $92.49 per capita, cooler than Texas’s $686.1 on 31,290,831. The shared pharmaceutical peak sits on that cooler ratio and on 1,162,765 awards. The $878.7M FY2026 slice is the recency cut on the smaller stock.

Texas’s $72.7B stacked stock, 530,634 awards, and $21.5B latest-year amount remain the larger dollar file. Read two pharmaceutical peaks as a same-label, unmatched-scale pair. Keep every dollar figure labeled as a USAspending.gov obligation.

How to read New Jersey versus Texas

Read Texas first on stacked dollars ($72.7B vs $8.1B), population (31,290,831 vs 9,500,851), spending per capita ($686.1 vs $92.49), and FY2026 ($21.5B vs $878.7M). Read New Jersey first on awards (1,162,765 vs 530,634). Note that both lead industries are pharmaceutical preparation manufacturing.

The comparison hub holds the tables. The New Jersey and Texas hubs hold agencies and recipients. Outlays are a different series. Cite USAspending.gov. Keep $92.49 and $686.1 labeled as Census-based obligation ratios.

Same pharmaceutical label, inverted award volume

Pharmaceutical preparation manufacturing is the lead NAICS on both $8.1B in New Jersey and $72.7B in Texas. The shared label does not produce shared scale. New Jersey’s 1,162,765 awards are a thicker action log on the smaller stock. Texas’s 530,634 awards sit on the larger stock. $92.49 per capita on 9,500,851 residents versus $686.1 on 31,290,831 is the intensity ranking. FY2026 of $878.7M versus $21.5B preserves Texas’s dollar lead.

A shared pharmaceutical peak is a first filter, not a matched mix. Cite USAspending.gov. Outlays are not in the packet. The comparison hub holds the tables. The New Jersey and Texas hubs hold agencies and recipients. Do not invent a mean from 1,162,765 or 530,634.

Questions

Does New Jersey or Texas have more federal spending?

Texas leads stacked USAspending.gov obligations $72.7B to New Jersey’s $8.1B, spending per capita $686.1 to $92.49, and FY2026 obligations $21.5B to $878.7M. New Jersey leads award volume 1,162,765 to 530,634. Population is 9,500,851 in New Jersey and 31,290,831 in Texas.

What industries lead in New Jersey and Texas?

Both states list pharmaceutical preparation manufacturing as the top industry. That shared label sits on $8.1B in New Jersey and $72.7B in Texas. Award counts are 1,162,765 in New Jersey and 530,634 in Texas. A shared peak is not a matched mix.

Does New Jersey have more awards than Texas?

Yes. The packet reports 1,162,765 awards in New Jersey and 530,634 in Texas. Stacked stocks still favor Texas, $72.7B versus $8.1B. These figures are USAspending.gov obligations, not outlays. Row count is not average award size.

Are New Jersey vs Texas figures Treasury outlays?

No. The $8.1B and $72.7B totals, and FY2026 amounts of $878.7M and $21.5B, are USAspending.gov obligations. Outlays are cash payments and can lag. Spending per capita ($92.49 vs $686.1) uses Census population where present. This packet does not publish outlays or average award size.